NEUCA S.A.
705.00
PLN
-5.00
(-0.70%)
ISIN
PLTRFRM00018
Return %
Stock
S&P 500
1Y
-4.86
14.20
3Y
0.00
81.12
5Y
-24.68
68.34
Capital Structure
PLN
•
in mil. unless spec.Working Capital
PLN
•
in mil. unless spec.Growth Rates
PLN
•
in mil. unless spec.Quarterly Revenue
PLN
•
in mil. unless spec.Quarterly Earnings Per Share
PLN
•
in mil. unless spec.Quarterly Dividends Per Share
PLN
•
in mil. unless spec.Company Description
- CEO
- Grzegorz Dzik
- Full Time Employees
- 4,738
- Sector
- Distribution services
- Industry
- Medical distributors
- Address
- ul. Forteczna 35-37 Torun KP Poland 87-100
- IPO Date
- Sep 30, 2004
- Website
- neuca.pl
- Similar Companies
- Business
- Neuca S.A. operates as a leading pharmaceutical wholesaler and healthcare services provider in Poland. The company distributes prescription (Rx) and over-the-counter (OTC) medicines, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, diagnostic and dressing materials under brands including Świat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic to pharmacies, medical professionals, and patients. Its business segments encompass wholesale distribution of pharmaceuticals; manufacture of medicines and pharmaceutical preparations; operation of a network of medical clinics; conducting clinical trials and outsourcing clinical research; telemedicine; healthcare e-commerce via platforms such as apteline.pl; and insurance activities including health insurance products and occupational medicine services. Neuca also offers marketing, advertising, IT solutions, and logistics services tailored for the pharmaceutical market. Founded in 1990 and headquartered in Toruń, Poland, Neuca serves approximately 9,000 pharmacies across the country and maintains a strong position with around 30% market share in pharmaceutical wholesale distribution. The company employs over 3,500 people across its subsidiaries. Recent strategic developments include a 2021 acquisition of a 50% stake in Global Pharma CM, a Polish manufacturer of medical devices and dietary supplements, aimed at expanding its manufacturing capabilities and R&D efforts in new product development. Neuca continuously invests in advancing medical technologies, automation of manufacturing processes, and synergistic growth within healthcare sectors. It remains committed to supporting independent pharmacies while growing its patient care network, clinical research activity, and e-health offerings. Neuca’s integrated business model combining wholesale pharmaceutical distribution with manufacturing, clinical services, telemedicine, and insurance solutions positions it uniquely in Poland’s healthcare market. The company focuses on enhancing customer satisfaction, strengthening its pharmacy partners, and expanding patient-centered services throughout the region, underpinned by steady revenue growth and operational improvements as reflected in recent financial results.